239 related articles for article (PubMed ID: 23994419)
61. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
[TBL] [Abstract][Full Text] [Related]
62. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
[TBL] [Abstract][Full Text] [Related]
63. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support.
Jennings DL; Williams CT; Morgan JA
ASAIO J; 2013; 59(5):526-7. PubMed ID: 23896772
[TBL] [Abstract][Full Text] [Related]
64. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
[TBL] [Abstract][Full Text] [Related]
65. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
[TBL] [Abstract][Full Text] [Related]
66. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
[TBL] [Abstract][Full Text] [Related]
67. Low bearing wear in explanted HeartMate II left ventricular assist devices after chronic clinical support.
Sundareswaran KS; Reichenbach SH; Masterson KB; Butler KC; Farrar DJ
ASAIO J; 2013; 59(1):41-5. PubMed ID: 23263335
[TBL] [Abstract][Full Text] [Related]
68. Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients.
Joyce D; Crow S; Li Z; Joyce L; Milano C; Rogers J; Villamizar-Ortiz N; Chen D
J Heart Lung Transplant; 2012 Jul; 31(7):750-6. PubMed ID: 22538169
[TBL] [Abstract][Full Text] [Related]
69. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
70. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
Shuhaiber J; Hur K; Gibbons R
J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
[TBL] [Abstract][Full Text] [Related]
71. Five-year results of patients supported by HeartMate II: outcomes and adverse events.
Hanke JS; Rojas SV; Mahr C; Schmidt AF; Zoch A; Dogan G; Feldmann C; Deniz E; Molitoris U; Bara C; Strüber M; Haverich A; Schmitto JD
Eur J Cardiothorac Surg; 2018 Feb; 53(2):422-427. PubMed ID: 28958073
[TBL] [Abstract][Full Text] [Related]
72. Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II.
Magruder JT; Grimm JC; Crawford TC; Tedford RJ; Russell SD; Sciortino CM; Whitman GJR; Shah AS
Ann Thorac Surg; 2017 May; 103(5):1505-1511. PubMed ID: 27765177
[TBL] [Abstract][Full Text] [Related]
73. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Myers S; Acker MA; Rogers J; Slaughter MS; Stevenson LW
J Heart Lung Transplant; 2015 Dec; 34(12):1515-26. PubMed ID: 26681121
[TBL] [Abstract][Full Text] [Related]
74. HAS-BLED and CHA₂DS₂-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation.
Koene RJ; Win S; Naksuk N; Adatya SN; Rosenbaum AN; John R; Eckman PM
J Card Fail; 2014 Nov; 20(11):800-7. PubMed ID: 25152496
[TBL] [Abstract][Full Text] [Related]
75. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support.
Maltais S; Anwer LA; Haglund NA; Cowger J; Shah P; Aaronson KD; Pagani FD; Dunlay SM; Singh R; Salerno CT; Stulak JM
J Card Fail; 2017 Dec; 23(12):852-858. PubMed ID: 28757150
[TBL] [Abstract][Full Text] [Related]
76. Readmissions after implantation of axial flow left ventricular assist device.
Hasin T; Marmor Y; Kremers W; Topilsky Y; Severson CJ; Schirger JA; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Stulak JM; Joyce L; Daly R; Park SJ; Kushwaha SS
J Am Coll Cardiol; 2013 Jan; 61(2):153-63. PubMed ID: 23219299
[TBL] [Abstract][Full Text] [Related]
77. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.
Guha A; Eshelbrenner CL; Richards DM; Monsour HP
Methodist Debakey Cardiovasc J; 2015; 11(1):24-7. PubMed ID: 25793026
[TBL] [Abstract][Full Text] [Related]
78. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
[TBL] [Abstract][Full Text] [Related]
79. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
[TBL] [Abstract][Full Text] [Related]
80. Anticoagulation management following left ventricular assist device implantation is similar across all provider strategies.
McDavid A; MacBrair K; Emani S; Yu L; Lee PHU; Whitson BA; Lampert BC; Agarwal R; Kilic A
Interact Cardiovasc Thorac Surg; 2018 Jan; 26(1):60-65. PubMed ID: 29049614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
